公司资料
Virpax Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- VRPX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月14日
—
市值
股价为何变动
Current closing-price context is not available for VRPX.
公司概览
业务概览
Virpax Pharmaceuticals is a specialty pharmaceutical company focused on non-opioid pain management and advanced drug-delivery concepts. Its story is built around addressing pain with differentiated formulations and delivery systems rather than traditional systemic therapy.
所在地与行业分类
Virpax is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and drug-delivery development.
商业模式特征
The company depends on clinical development, regulatory pathway clarity, and the ability to create value from a narrow pain portfolio. Investors usually watch formulation progress, safety, and commercialization options.
生物医药行业定位
Virpax occupies a small pain-management niche within biotech-adjacent specialty pharma. The stock is sensitive to proof that its delivery approach can matter in a crowded pain market.
未来催化剂
- Virpax’s catalysts are pain and CNS delivery programs, plus any update that clarifies whether the company can still keep the platform credible. The next step matters because the stock is still data-sensitive.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。